|
1
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ebrahimi F, Gopalan V, Smith RA and Lam
AK: miR-126 in human cancers: Clinical roles and current
perspectives. Exp Mol Pathol. 96:98–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Han L, Zhang A, Wang G, Jia Z,
Yang Y, Yue X, Pu P, Shen C and Kang C: Adenovirus-mediated shRNAs
for co-repression of miR-221 and miR-222 expression and function in
glioblastoma cells. Oncol Rep. 25:97–105. 2011.PubMed/NCBI
|
|
5
|
Mittal SP, Mathai J, Kulkarni AP, Pal JK
and Chattopadhyay S: miR-320a regulates erythroid differentiation
through MAR binding protein SMAR1. Int J Biochem Cell Biol.
45:2519–2529. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miller TE, Ghoshal K, Ramaswamy B, Roy S,
Datta J, Shapiro CL, Jacob S and Majumder S: MicroRNA-221/222
confers tamoxifen resistance in breast cancer by Targeting p27Kip1.
J Biol Chem. 283:29897–29903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang C, Zhang J, Zhang A, Wang Y, Han L,
You Y, Pu P and Kang C: PUMA is a novel target of miR-221/222 in
human epithelial cancers. Int J Oncol. 37:1621–1626.
2010.PubMed/NCBI
|
|
8
|
Quintavalle C, Garofalo M, Zanca C, Romano
G, Iaboni M, del Basso De Caro M, Martinez-Montero JC, Incoronato
M, Nuovo G, Croce CM and Condorelli G: miR-221/222 overexpession in
human glioblastoma increases invasiveness by targeting the protein
phosphate PTPµ. Oncogene. 31:858–868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jikuzono T, Kawamoto M, Yoshitake H,
Kikuchi K, Akasu H, Ishikawa H, Hirokawa M, Miyauchi A, Tsuchiya S,
Shimizu K and Takizawa T: The miR-221/222 cluster, miR-10b and
miR-92a are highly upregulated in metastatic minimally invasive
follicular thyroid carcinoma. Int J Oncol. 42:1858–1868.
2013.PubMed/NCBI
|
|
10
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ebert MS and Sharp PA: MicroRNA sponges:
Progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou LJ, Zhao W, Jiang FF, Liu ZF, Ou Yang
Y and Yu DS: Construction and validation of microRNA-221/222 sponge
vector. Chinese Journal of Stomatological Research (Electronic
Version). 106–112. 2015.
|
|
13
|
Rahmani A, Alzohairy M, Babiker AY, Rizvi
MA and Elkarimahmad HG: Clinicopathological significance of PTEN
and bcl2 expressions in oral squamous cell carcinoma. Int J Clin
Exp Pathol. 5:965–971. 2012.PubMed/NCBI
|
|
14
|
Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y,
Zhang Y, Hua S, Fu Q, Zhao M, et al: Downregulation of FAP
suppresses cell proliferation and metastasis through PTEN/PI3K/AKT
and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death
Dis. 5:e11552014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dorr C, Janik C, Weg M, Been RA, Bader J,
Kang R, Ng B, Foran L, Landman SR, O'Sullivan MG, et al: Transposon
mutagenesis screen identifies potential lung cancer drivers and
CUL3 as a tumor suppressor. Mol Cancer Res. 13:1238–1247. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin PC, Lin JK, Lin HH, Lan YT, Lin CC,
Yang SH, Chen WS, Liang WY, Jiang JK and Chang SC: A comprehensive
analysis of phosphatase and tensin homolog deleted on chromosome 10
(PTEN) loss in colorectal cancer. World J Surg Oncol. 13:1862015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ,
Kim JH, Yin J, Yoo H, Lee SH and Park JB: Silencing of MicroRNA-21
confers radio-sensitivity through Inhibition of the PI3K/AKT
pathway and enhancing autophagy in malignant glioma cell lines.
PLoS One. 7:e474492012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sarkar S, Dubaybo H, Ali S, Goncalves P,
Kollepara SL, Sethi S, Philip PA and Li Y: Down-regulation of
miR-221 inhibits proliferation of pancreatic cancer cells through
up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am J Cancer
Res. 3:465–477. 2013.PubMed/NCBI
|
|
19
|
Fang L, Li H, Wang L, Hu J, Jin T, Wang J
and Yang BB: MicroRNA-17-5p promotes chemotherapeutic drug
resistance and tumour metastasis of colorectal cancer by repressing
PTEN expression. Oncotarget. 5:2974–2987. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beg S, Siraj AK, Prabhakaran S, Jehan Z,
Ajarim D, Al-Dayel F, Tulbah A and Al-Kuraya KS: Loss of PTEN
expression is associated with aggressive behavior and poor
prognosis in Middle Eastern triple-negative breast cancer. Breast
Cancer Res Treat. 151:541–553. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun MM, Zhang MZ, Chen Y, Li SL, Zhang W,
Ya GW and Chen KS: Effect of PTEN antisense oligonucleotide on
oesophageal squamous cell carcinoma cell lines. J Int Med Res.
40:2098–2108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and
Li GX: Anti-miRNA-221 sensitizes human colorectal carcinoma cells
to radiation by upregulating PTEN. World J Gastroentero.
19:9307–9317. 2013. View Article : Google Scholar
|
|
23
|
Jia LF, Huang YP, Zheng YF, Lyu MY, Wei
SB, Meng Z and Gan YH: miR-29b suppresses proliferation, migration,
and invasion of tongue squamous cell carcinoma through PTEN-AKT
signaling pathway by targeting Sp1. Oral Oncol. 50:1062–1071. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang D, Ni Z, Xu X and Xiao J: MiR-32
Functions as a tumor suppressor and directly targets EZH2 in human
oral squamous cell carcinoma. Med Sci Monit. 20:2527–2535. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang C, Shen WG, Liu CJ, Chen YW, Lu HH,
Tsai MM and Lin SC: miR-221 and miR-222 expression increased the
growth and tumorigenesis of oral carcinoma cells. J Oral Pathol
Med. 40:560–566. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krützfeldt J, Rajewsky N, Braich R, Rajeev
KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in
vivo with ‘antagomirs’. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kluiver J, Slezak-Prochazka I,
Smigielska-Czepiel K, Halsema N, Kroesen BJ and van den Berg A:
Generation of miRNA sponge constructs. Methods. 58:113–117. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kluiver J, Gibcus JH, Hettinga C, Adema A,
Richter MK, Halsema N, Slezak-Prochazka I, Ding Y, Kroesen BJ and
van den Berg A: Rapid generation of MicroRNA Sponges for MicroRNA
Inhibition. PLoS One. 7:e292752012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang F, Zhao W, Zhou L, Zhang L, Liu Z
and Yu D: miR-222 regulates the cell biological behavior of oral
squamous cell carcinoma by targeting PUMA. Oncol Rep. 31:1255–1262.
2014.PubMed/NCBI
|
|
31
|
Kurasawa Y, Shiiba M, Nakamura M, Fushimi
K, Ishigami T, Bukawa H, Yokoe H, Uzawa K and Tanzawa H: PTEN
expression and methylation status in oral squamous cell carcinoma.
Oncol Rep. 19:1429–1434. 2008.PubMed/NCBI
|
|
32
|
Cohen Y, Goldenberg-Cohen N, Shalmon B,
Shani T, Oren S, Amariglio N, Dratviman-Storobinsky O,
Shnaiderman-Shapiro A, Yahalom R, Kaplan I and Hirshberg A:
Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous
cell carcinoma. Oral Oncol. 47:946–950. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu YZ, Wu K, Huang J, Liu Y, Wang X, Meng
ZJ, Yuan SX, Wang DX, Luo JY, Zuo GW, et al: The PTEN/PI3K/Akt and
Wnt/β-catenin signaling pathways are involved in the inhibitory
effect of resveratrol on human colon cancer cell proliferation. Int
J Oncol. 45:104–112. 2014.PubMed/NCBI
|
|
34
|
Giudice FS and Squarize CH: The
determinants of head and neck cancer: Unmasking the PI3K pathway
mutations. J Carcinog Mutagen. (Suppl 5): pii: 003. 2013.PubMed/NCBI
|
|
35
|
Xie Q, Yan Y, Huang Z, Zhong X and Huang
L: MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell
proliferation and BCNU resistance in human glioblastoma.
Neuropathology. 34:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao F, Huang W, Zhang Y, Tang S, Zheng L,
Ma F, Wang Y, Tang H and Li X: Hes1 promotes cell proliferation and
migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human
colon cancer. Oncotarget. 6:38667–38680. 2015.PubMed/NCBI
|
